We are live on ! Find out more
PCM

Polaris Capital Management Portfolio holdings

AUM $1.06B
1-Year Est. Return 40.82%
This Fund
S&P 500
This Quarter Est. Return
+6.77%
1 Year Est. Return
+40.82%
3 Year Est. Return
+94.3%
5 Year Est. Return
+113.49%
10 Year Est. Return
+358.47%
AUM
$3.1B
AUM Growth
+$51.4M
Cap. Flow
+$102M
Cap. Flow %
3.28%
Top 10 Hldgs %
48.78%
Holding
106
New
4
Increased
29
Reduced
19
Closed
3

Top Buys

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$224M
2
NEE icon
NextEra Energy
NEE
+$1.22M
3
MTB icon
M&T Bank
MTB
+$1.11M
4
SUPN icon
Supernus Pharmaceuticals
SUPN
+$1.01M
5
ALE
Allete
ALE
+$989K

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$52.7M
2
DGX icon
Quest Diagnostics
DGX
+$44.3M
3
BPOP icon
Popular Inc
BPOP
+$18.6M
4
INFY icon
Infosys
INFY
+$13.8M
5
CCEP icon
Coca-Cola Europacific Partners
CCEP
+$1.93M

Sector Composition

Rank Sector Weight
1 Financials 27.15%
2 Healthcare 18.38%
3 Technology 13.56%
4 Consumer Staples 10.23%
5 Consumer Discretionary 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MEOH icon
101
Methanex
MEOH
$4.12B
$41K ﹤0.01%
1,250
– –
DGX icon
102
Quest Diagnostics
DGX
$26.3B
$40K ﹤0.01%
300
-338,534
-100% -$44.3M
DECK icon
103
Deckers Outdoor
DECK
$13.3B
– –
-16,200
Closed -$891K
EPR icon
104
EPR Properties
EPR
$4.77B
– –
-19,810
Closed -$952K
ALXN
105
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-306,900
Closed -$52.7M
1 2 3 4
5

Similar funds

BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
EC
E20 Capital Hong Kong $1.07B AUM
ZIG
Zuckerman Investment Group Chicago, Illinois $1.07B AUM 29.43% 1-Year Est. Return
MWA
Monograph Wealth Advisors Manhattan Beach, California $1.05B AUM 23.2% 1-Year Est. Return
DCP
Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return
SFP
Shepherd Financial Partners Winchester, Massachusetts $1.05B AUM 22.07% 1-Year Est. Return
PP
Passaic Partners Newark, New Jersey $1.07B AUM 16.56% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Polaris Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Polaris Capital Management held 106 positions worth $3.1B, up 1.7% from $3.05B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Polaris Capital Management deployed $102M of net new capital in Q2 2021, opening 4 new positions and adding to 29 existing holdings. Its largest new stake was Jazz Pharmaceuticals: 1,292,760 shares worth $230M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 30% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Quest Diagnostics, an estimated $44.3M trimmed.

  • Polaris Capital Management's largest Q2 2021 buy was Jazz Pharmaceuticals: 1,292,760 shares worth $230M.
  • Polaris Capital Management added most to NextEra Energy in Q2 2021, an estimated $1.22M increase.
  • Polaris Capital Management's biggest Q2 2021 reduction was Quest Diagnostics, cutting an estimated $44.3M.
  • Polaris Capital Management fully exited Alexion Pharmaceuticals in Q2 2021, selling an estimated $52.7M.
  • Polaris Capital Management's ten largest holdings make up 49% of its $3.1B portfolio in Q2 2021.
  • Polaris Capital Management opened 4 new positions and closed 3 in Q2 2021.
  • Polaris Capital Management's portfolio value rose 1.7% quarter-over-quarter to $3.1B.

Based on Polaris Capital Management's 13F filing for Q2 2021, filed 10 Aug 2021.